BioSpace News Archive

Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and reliable genome analysis services have announced their partnership.

AbbVie announced the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of upadacitinib for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.1-4

Teva Pharmaceutical Industries Ltd. announced its intention to issue $2,060,000,000 of sustainability-linked senior notes.

HUTCHMED Limited announces that it has completed patient enrollment of Phase II registration trial of amdizalisib in patients with relapsed or refractory follicular lymphoma, a subtype of non-Hodgkin’s lymphoma.

CN Bio, a leading Organ-on-a-Chip company that designs and manufactures single-and multi-organ microphysiological systems, announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput System.

Evelo Biosciences, Inc. today announced that its first extracellular vesicle (EV) product candidate, EDP2939, has progressed to dosing in a Phase 2 psoriasis clinical trial after completing a safety and tolerability review from a first cohort of human volunteers.

AbbVie (NYSE: ABBV) will present further analyses on SKYRIZI® (risankizumab) in Crohn’s disease (CD) and RINVOQ® (upadacitinib) in ulcerative colitis (UC) as well as the investigational use of upadacitinib in CD at the 18th Congress of European Crohn’s and Colitis Organisation (ECCO), to be held March 1-4 in Copenhagen, Denmark.

UC San Diego and Point Loma Nazarene University will host the 22nd Kyoto Prize Symposium to celebrate the 37th annual laureates of the Kyoto Prize, Japan’s highest private award for global achievement.

Annexon, Inc. today announced that Douglas Love, president and chief executive officer, will participate in a fireside chat during the 43rd Annual Cowen Healthcare Conference on Monday, March 6, 2023 at 1:30 p.m. ET in Boston.

ConcertAI’s TeraRecon has announced its Eureka Clinical AI platform is now available to European healthcare providers.